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Interaction with biological material can alter physicochemical parameters of magnetic nanoparticles 
and might thereby change their magnetic behavior with potentially important implications for 
various nanoparticle applications. Little is known about changes of the magnetic behavior that occur 
during the initial phase of cell binding and uptake. We investigate the magnetic behavior of very small 
superparamagnetic iron-oxide nanoparticles (VSOP) during initial contact with THP-1 monocytes. 
We combine real-time magnetic particle spectroscopy (MPS), a fast and sensitive method for specific 
detection of magnetic nanoparticles in biological specimen with high-pressure-freezing/freeze-
substitution transmission electron microscopy (HPF/FS-TEM), enabling us to generate snapshots of 
the interaction of VSOP with the cellular glycocalyx. MPS reveals significant changes of the dynamic 
magnetic behavior within seconds after VSOP injection into monocyte suspensions that correlate with 
the formation of nanoparticle clusters in the glycocalyx. The combination of real-time MPS and HPF/FS-
TEM provides an ideal platform to analyze magnetic behaviors of nanoparticles upon interaction with 
cells and tissues.
Magnetic iron oxide nanoparticles (MNP) serve in a broad spectrum of biomedical applications ranging from 
hyperthermia treatment of cancer over targeted drug delivery to contrast enhancement in magnetic resonance 
imaging (MRI) because of their special magnetic behavior in external magnetic fields1. This behavior is deter-
mined by the magnetic properties of MNP, which mostly depend on their composition, structure and size of the 
core. Additionally, physicochemical parameters such as surface coating and ζ potential as well as the mobility and 
aggregation state may further affect the magnetic behavior of MNP. As the interaction with biological material 
can alter the physicochemical parameters of the MNP their magnetic behavior may change as well2–5. While inter-
mediate and long-term changes of MNP magnetism during the biodegradation process of cell-internalized MNP 
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are relatively well investigated6–9, little is known about the change of the magnetic properties of MNP during the 
initial phase of cell contact and uptake.
Monitoring of the magnetic behavior of MNP during initial cell contact requires sensitive techniques with a 
high temporal resolution and the possibility to analyze living cells. Magnetic particle spectroscopy (MPS) was 
proven to be a fast, convenient and highly sensitive method for the specific detection of MNP in biological spec-
imen10,11. By means of MPS the dynamic magnetic behavior of MNP under influence of an oscillating external 
magnetic field can be measured. The Fourier spectrum (An) of the measured temporal response is MNP specific 
and allows for sensitive quantification of MNP iron content, without being hampered by non-particular iron11. 
The amplitude and shape of the MPS spectrum is determined by many factors of influence. Apart from the main 
influential variables such as size distribution and magnetic anisotropy of the particles12, binding state13, viscos-
ity14, and interparticle interactions15, also modulate the spectral signature of MNP in MPS. The slope of the MPS 
spectrum can be parameterized by the concentration independent ratio of the fifth and third harmonic (A5/A3 
ratio)5. Changes of the dynamic magnetic behavior (expressed by a change in A5/A3 ratio) caused by aggregation, 
viscosity changes or biodegradation can be assessed in biological systems whereby the extent of signal change 
strongly depends on the initial MNP size16. Importantly, MPS enables analyses in living cells.
Using MPS we have previously observed changes of the dynamic magnetic behavior of citrate-coated very 
small superparamagnetic iron oxide nanoparticles (VSOP), which have entered the clinical development up to 
phase II trials as a contrast agent for MRI17, during incubation with THP-1 monocytes2. The human monocytic 
cell line THP-1 is widely used to study monocyte/macrophage biology in cell culture systems. Monocytes and 
macrophages are cells of the innate immune system that have been shown to incorporate VSOP in in vivo and 
in vitro experiments2,18,19. In this previous study, we analyzed washed cell-pellets with MPS and observed a sig-
nificant increase in the A5/A3 ratio of VSOP three minutes after the start of cell incubation, followed by a steady 
decrease towards the baseline level over the next 24 h2.
Before an MNP can enter a cell, it has to pass the glycocalyx (GCX), a membrane anchored polymer layer 
consisting mainly of proteoglycans and hyaluronic acid. For a long time, this structure was neglected, but recently 
it has been recognized how decisive the GCX is for cellular bioprocesses (e.g. cell migration, proliferation, adhe-
sion) and for the uptake of nanoparticles20–22.
In the current study, we therefore hypothesize that the interaction of VSOP with the GCX of THP-1 cells dur-
ing their very initial contact causes physicochemical alterations of the nanoparticles that are responsible for rapid 
changes of their dynamic magnetic behavior, i.e. the increase of the A5/A3 ratio, after cell contact.
To test our hypothesis, we conducted real-time in situ MPS measurements during the first seconds and min-
utes of incubation of THP-1 cells with VSOP, to monitor changes of the A5/A3 ratio during the early VSOP-cell 
interaction without influencing the interaction by additional sample preparation steps. To visualize the associa-
tion of VSOP with the GCX of THP-1 cells we used the technique of high-pressure-freezing/freeze-substitution 
transmission electron microscopy (HPF/FS-TEM), which was shown to largely preserve the hydrated configura-
tion of the endothelial GCX23,24.
Methods
Very small superparamagnetic iron oxide particles (VSOP). All chemicals and solvents were 
obtained from Sigma-Aldrich, Germany, unless otherwise stated. VSOP used in this study were synthesized as 
previously described in detail2. The mean hydrodynamic diameter of the nanoparticles (as measured by laser light 
scattering) was 8.7–11.0 nm with a polydispersity index of 0.085. The crystallite size measured by TEM (largest 
diameter of 500 crystals evaluated) was 6.8 ± 2 nm. The final ferrous iron ion content of 0.9% (molar ratio total 
iron) indicates nearly complete oxidation to maghemite. Selected area electron diffraction revealed a pure mag-
netite/maghemite pattern as previously published (PMID: 29017510).
Cell culture and VSOP incubation. THP-1 cells (ATCC, Germany) were cultured in suspension in RPMI 
medium (1640; Invitrogen, Germany) supplemented with fetal calf serum (10% FCS, Biochrom, Germany), 
100 U/mL penicillin (Invitrogen), 100 µg/mL streptomycin (Invitrogen), as described previously2.
In a first set of experiments, 106 THP-1 cells suspended in 100 µL of pre-warmed PBS were transferred to 
a glass tube and placed into the MPS spectrometer at 37 °C. After starting the MPS measurements, 100 µL of a 
VSOP solution in PBS were added through a syringe and mixed briefly by repeated pumping, while the glass tube 
remained in the spectrometer and was continuously measured by MPS (Bruker, Germany). The experiments 
were conducted in quintuplicate using a VSOP iron concentration of 0.5 mmol/L and 2.4 mmol/L, respectively. 
As control 100 µL VSOP with 0.6 mmol/L iron were added to 100 µL PBS without cells.
In a second set of experiments THP-1 cells were incubated with VSOP outside the spectrometer (ex situ), as 
described previously2,18. THP-1 cells (10 mL with 5·106 cells/mL) were incubated with VSOP (0.5 mmol/L and 
2.4 mmol/L). After incubation for 300 s, 600 s, and 900 s aliquots of 1 ml each were collected and centrifuged for 
1 min at 500 g, and washed 2 times with PBS. Details of the analysis conditions are described below.
Magnetic particle spectroscopy. Magnetic particle spectroscopy (MPS) measurements on VSOP samples 
were performed using a commercial magnetic particle spectrometer (MPS-3, Bruker, Germany) as previously 
described in detail11. Primarily, this device is dedicated to assess the performance of MNP as tracers for a novel 
imaging modality called magnetic particle imaging (MPI). MPS specifically detects the non-linear magnetic 
response of MNP exposed to an oscillating magnetic field. Therefore, biological tissue and paramagnetic blood 
iron do not contribute to the MPS signal.
MPS measurements in standard operation mode were performed as described elsewhere6. To investigate the 
MNP interaction with cells in situ real-time MPS measurements were performed. Therefore, 106 cells diluted in 
100 μL PBS were initially assembled in a glass tube (Bruker NMS PC 7.5). After placing the glass tube into the 
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MPS pick-up coil repetitive measurements were started without VSOP to check for magnetic impurities. Over a 
time course of 10 min the MPS spectra were recorded every 4 s to improve the signal-to-noise-ratio. After the first 
measurements, 100 µL of VSOP with an iron concentration of c(Fe) = 0.5 mmol/L and 2.4 mmol/L were added sta-
bilized in PBS and mixed thoroughly (5 times). To transfer the sample from the pipette to the bottom part of the 
glass tube a flexible tubing (Rotilabo-FEP, Carl Roth GmbH, Germany) was used to extend the tip. As a control 
the same procedure was applied to measure the time dependent behavior of 100 µL VSOP (c(Fe) = 0.6 mmol/L) 
after injection in medium (100 µL PBS) only without cells.
High-pressure-freezing/freeze-substitution transmission electron microscopy. THP-1 cells were 
incubated with 1 mmol/l VSOP in RPMI medium supplemented with 10% fetal calf serum (FCS) for the indicated 
times (3 min, 30 min, 180 min) followed by centrifugation of 1 ml containing 106 THP-1 cells (3000 rpm for 2 min 
at room temperature). The cell pellet was re-suspended in 20 µl RPMI medium, transferred into 3 mm copper 
gold-plated specimen carrier (200 µm indentation, Leica, Germany), coated with 1-hexadecene (Sigma-Aldrich, 
Germany) and immediately frozen in an EM ICE High Pressure Freezer (Leica, Germany) after reaching 2100 bar 
under liquid nitrogen. The detailed process of high-pressure freezing has been described previously23.
Freeze-substitution and embedding. Frozen samples were collected in liquid nitrogen and trans-
ferred into a freeze-substitution chamber (Leica EM AFS; Leica, Germany), where they were freeze substituted 
for 12–14 hours at −90 °C in acetone containing 1% osmium tetroxide (OsO4; Electron Microscopy Sciences, 
Germany) to enhance contrast and simultaneously stabilize the glycocalyx. Subsequently, the temperature was 
gradually increased (5 °C/1 h) to 20 °C. Afterwards, the cells were centrifuged (1000 rpm, 3 min), washed with 
acetone (Roche, Germany) and centrifuged again. After rinsing several times with acetone, the dehydrated sam-
ples were infiltrated first with HPMA (2-hydroxypropyl methacrylamide; Sigma-Aldrich, Germany), centrifuged 
at 3000 rpm for 5 min and finally infiltrated overnight with HPMA-Epon mix (1:1). Suspension cells were further 
centrifuged at 5000 rpm for 5 min and infiltrated with pure freshly prepared Epon for several hours. Finally, the 
samples were embedded in Epon and polymerized overnight at 60 °C.
Transmission electron microscopy. Ultrathin sections (60 nm) of embedded cells were cut using an ultra-
microtome (Reichert Ultracut S, Leica, Germany) with a diamond knife (Diatome, Switzerland) and mounted on 
300-mesh copper grids (Plano, Germany). Sections were examined, without further staining, using a Zeiss trans-
mission electron microscope 912 (TEM-912, Carl Zeiss, Germany) operating at 80 kV and equipped with a digital 
camera (Proscan 2 K Slow-Scan CCD-Camera, Carl Zeiss, Germany). Digital image acquisition was performed 
using the iTEM software (Olympus GmbH, Germany)2,18.
Data analyses. All MPS experiments were performed in quintuplicate, unless otherwise stated. Were appro-
priate, data are presented as mean ± standard deviations with a coverage factor of k = 1 (i.e. a confidence level 
of about 68%). The limit of detection was determined according to guidance of the International Union of Pure 
and Applied Chemistry (IUPAC) as mean + 3x standard deviation of empty sample holder measurements with a 
coverage factor of k = 1 as well.
Results
Analysis of pre-conditions for a real-time in situ MPS monitoring. We first analyzed in which con-
centration range VSOP can be detected by MPS. Therefore, serial dilutions of VSOP in liquid suspension (free 
VSOP) were measured by MPS and the limit of detection (LOD) of the third A3 and fifth A5 harmonic amplitude 
of the MPS signal was assessed. The amplitudes A3 and A5 of the MPS signal showed a highly linear dependency 
on the corresponding iron mass above their LOD of less than 200 ng(Fe) (Fig. 1). Furthermore, the shape of the 
MPS spectrum, represented by the ratio of the fifth A5 to the third A3 harmonic amplitude, remains constant 
within the examined concentration range at 6%. This further indicates that the dynamic magnetic behavior is not 
affected by changing concentrations of VSOP, which is a pre-condition for a real-time in situ MPS monitoring of 
VSOP during incubation with THP-1 cells. To detect the binding of VSOP to THP-1 cells as early as possible by 
real-time in situ MPS the addition of too much free VSOP should be avoided. Thus, the upper limit of m(Fe) was 
estimated to be 20 µg(Fe), which is the maximum VSOP uptake capacity of 106 THP-1 cells2.
Time resolved MPS measurements detect significant changes in the dynamic magnetic behav-
ior of VSOP immediately after cell contact. Figure 2a shows the results of ex situ MPS measurement 
of THP-1 cells after incubation with VSOP for 300 s, 600 s, and 900 s. The A5/A3 ratio of cell bound VSOP has 
increased to about 8% already after 300 s, irrespective of the VSOP concentration used for incubation. As the 
A5/A3 ratio resembles the magnetic properties of VSOP, this observation indicates rapid physicochemical changes 
during cell contact, which was reported previously for VSOP of a different formulation2.
In order to investigate the very first contact of VSOP with THP-1 cells, we took advantage of the capability of 
MPS to perform in situ real-time measurements at a minimum temporal resolution of 20 µs. Figure 2b displays 
the temporal evolution of the measured A5/A3 ratio after injection of VSOP into cell medium (PBS) only. The 
mean A5/A3 ratio of VSOP in PBS was 5.8% ± 0.2%, which is close to the A5/A3 ratio of free VSOP determined 
previously. This value remains nearly constant (coefficient of variation 2%) during the entire 12.5 minutes of 
real-time MPS scans. This control experiment proofs that VSOP were still freely mobile in the cell medium and 
the dynamic magnetic behavior of VSOP was not altered by the MPS measurement procedure itself (field ampli-
tude, injection). Subsequently, a tube containing the THP-1 monocytes was placed into the MPS device and 
VSOP were directly added to this tube during ongoing MPS measurements. Figure 2c shows the resulting time 
course of the A5/A3 ratio, which was characterized by a continuous increase of the A5/A3 ratio for both amounts 
of added VSOP (m1 and m2). For the lower amount m1 of VSOP (filled blue circles) the A5/A3 ratio had already 
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increased to 6.7% ± 0.5% within the first 4 s after addition to THP-1 cells. The mean A5/A3 ratio continuously 
increased throughout the entire incubation period and finally reached a value of 7.4% ± 0.3% after 12.5 minutes, 
which corresponds to an increase of about 31% from baseline. The injection of a higher amount m2 of VSOP 
resulted in a slightly lower change of the A5/A3 ratio (filled red circles), indicating a higher proportion of VSOP 
that remained unbound and freely mobile in the sample. With the higher amount m2, the A5/A3 ratio finally 
reached a value of 6.83% ± 0.07% (increase of 17% from baseline).
The quantified nanoparticular iron amount remained unchanged during the experiments as quantified by 
MPS and therefore a potential dissolution of the MNP can be excluded.
Changes of the magnetic behavior of VSOP immediately after cell contact correlate with VSOP 
compartmentalization and clustering in the glycocalyx. Imaging the interaction of the fragile gly-
cocalyx with nanoparticles by TEM is challenging. Conventional sample preparation for TEM results in a nearly 
complete breakdown of the glycocalyx structure. By using HPF/FS-TEM we were able to visualize the glycocalyx 
of THP-1 cells as a several µm thick mesh-like structure (Fig. 3).
Figure 4 shows HPF/FS-TEM images of VSOP-labeled monocytes after the indicated incubation times at 
a high magnification to visualize the nanoparticles. At 3 minutes after the start of incubation, the majority of 
cell-bound VSOP were observed in small clusters distributed within the glycocalyx and as clusters directly on 
the cell membrane surface. Membrane invaginations associated with particle clusters indicated first endocytosis 
processes at this early time point of incubation. At later stages (30 minutes and 3 hours after incubation), the 
vast majority of cell-bound particles were found in cytoplasmic endosomes containing larger clusters of several 
hundred VSOP.
Discussion
In this study we observed a significant change of the dynamic magnetic behavior of VSOP during the initial 
contact of VSOP with THP-1 monocytes that correlated with compartmentalization and clustering of the nano-
particles in the glycocalyx.
This was achieved by taking advantage of the capability of MPS to perform in situ magnetic analyses of mag-
netic nanoparticles in a suspension with living cells and to monitor conformational changes in real time. Due to 
the different spectral signature of free (dispersed) and cell bound (clustered) VSOP, we were able to analyze the 
temporal change of VSOP states during incubation with THP-1 monocytes. Therefore, we used the A5/A3 ratio, 
which serves as a concentration independent parameter for the spectral signature of VSOP in MPS and allows to 
monitor the transition process from free to cell bound VSOP.
We observed a continuous increase of the MPS harmonic ratio starting from the value of dispersed (free) up 
to clustered (cell bound) particles when VSOP were injected into cell suspensions. Conversely, no MPS signal 
change was measured after injection of VSOP into cell medium (PBS) only.
Interestingly, we observed a change of the spectral signature of VSOP in MPS towards higher values of 
the A5/A3 ratio, which is contrary to the commonly observed decrease of the A5/A3 ratio that occurs during 
Figure 1. MPS measurements at Bˆ = 25 mT of VSOP in liquid suspension. MPS signals were acquired over a 
dilution range of the VSOP samples from 65 µg(Fe) down to 3 ng(Fe) iron. The uncertainty bars indicate the 
intrinsic noise of the MPS device determined by empty sample holder measurements (n = 100). The upper 
graph shows the ratio of the third A3 to the fifth A5 harmonic amplitude representing the concentration 
independent slope of the MPS spectrum (grey circles) showing a mean A5/A3 ratio of 6.05% (solid line). The 
lower graph displays that the signal amplitudes A3 (red triangles) and A5 (blue squares) are decreasing linearly 
with sample iron content. The limit of detection (LOD) of the respective harmonic amplitude results from 20 
repeated measurements of an empty sample holder (dashed lines).
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progressive aggregation3,4,25 or cellular uptake26,27 of other MNP. This can be explained by the fact that such 
experiments were mostly performed with MNP of larger size and magnetic moment sufficient to deploy a rich 
harmonic spectrum in MPS, which is associated with a superior performance of these MNP in MPI. Magnetic 
dipolar interactions occurring between those large MNP in an aggregate lead to a reduced frequency response 
compared to non-interacting MNP, i.e. a lower spectral response and A5/A3 ratio in MPS. Due to the weak mag-
netic moment of the small sized VSOP, magnetic dipolar interactions have a positive effect on the frequency 
response. This was shown by Berkov et al. who found from numerical simulations that the magnetic dipolar inter-
action can either decrease or increase the frequency response of interacting MNP depending on the anisotropy 
of the individual MNP28,29.
Compared to our previously published experiments on washed pellets of VSOP-loaded cells2, we now detected 
significantly lower absolute values of the A5/A3 ratio both at baseline and after incubation with cells. As indicated 
Figure 2. Cell binding and uptake of VSOP measured by MPS at Bˆ = 25 mT. (a) The mean and standard 
deviation of the MPS signal of cell pellets taken after 300 s, 600 s, and 900 s after start of VSOP incubation 
(n = 3). The A5/A3 ratio significantly increases for cell bound VSOP regardless of the iron amount used for 
incubation (blue and red circles). (b) Time dependent MPS signal of VSOP directly injected into medium only 
(PBS). The A5/A3 ratio (blue circles) does not change with time compared to the initial state (short dashed line). 
The uncertainty bars indicate the standard deviation of five replicated experiments (n = 5). (c) Time dependent 
MPS signal of VSOP directly injected into PBS with 106 suspended THP-1 cells. A total iron amount of 2.8 µg 
(blue circles) and 13.7 µg (red circles) was used. A continuous increase of the A5/A3 ratio from the initial state to 
the bound VSOP state was observed depending on the applied iron amount. The uncertainty bars indicate the 
standard deviation of five replicated experiments (n = 5).
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by their MPS spectral signatures, these differences in the absolute values between the VSOP batch used in the 
previous study2 and the currently used one might be caused by a different size distribution of the nanoparticles 
observed with DLS (PDI 0.39 and 0.107 for previous batch and new batch, respectively) with a higher content of 
larger entities in the previous batch. Importantly, however, the relative increase in the A5/A3 ratio between the 
unbound stage and the cell-bound stage is strikingly similar around 30% for both VSOP batches (18.1% ± 0.1% 
to 24% ± 1% and 5.8% ± 0.2% to 7.4% ± 0.3% for previous batch and new batch, respectively)2, indicating that 
the same ultrastructural and magnetic alterations occurred.
Furthermore, the injection of a higher amount of VSOP resulted in a slightly lower change of the A5/A3 ratio. 
This indicates a higher proportion of VSOP that remained unbound and freely mobile in the sample. The obser-
vations from the ex situ experiments are in line with this hypothesis. For ex situ measurements, the cells were 
washed two times before the pellet was analyzed by MPS. These washing steps should have largely removed 
unbound nanoparticles, which have a lower A5/A3 ratio. Therefore, this approach leads to detection of the A5/A3 
ratio of cell-bound VSOP only. Obviously, higher amounts of added VSOP do not seem to directly translate into 
higher amounts of VSOP in the glycocalyx. A potential explanation might be that VSOP only bind to specific 
domains within the glycocalyx or that changes in the electric charge distribution in the glycocalyx prevent further 
VSOP from entering the glycocalyx, so that only a certain amount of VSOP can be bound at a time. Another pos-
sibility is that, after a certain amount has been bound, it might just take more time for additional VSOP to enter 
the glycocalyx.
To correlate the observed MPS signal changes with morphological changes, we used the technique of 
high-pressure freezing with subsequent freeze substitution to fix our TEM samples. Chemical formaldehyde 
or glutaraldehyde based fixation methods inevitably induce strong ultrastructural changes that primarily effect 
water-rich labile components like the proteoglycans and glycosaminoglycans of the ECM, which is therefore 
almost completely lost during conventional fixation. HPF/FS-TEM overcomes these issues by simultaneously 
fixing all macromolecules in their hydrated biological configuration within milliseconds23. The rapid cooling pro-
cess combined with the high pressure leads to the immediate formation of vitrified ice without any crystals23. In 
the subsequent freeze-substitution process, water is substituted by acetone and samples are slowly brought back to 
room temperature before the embedding process continues. Beside the much better ultrastructural preservation, 
HPF/FS-TEM also improves antigenicity for subsequent post-embedding immuno-labeling23. The major draw-
backs of the method are its labor and cost expenses and the need for specific high pressure freezing and freeze 
substitution devices.
Using HPF/FS-TEM we were able to generate snapshots of the rapid and dynamic interaction of VSOP with 
the glycocalyx of THP-1 cells during the early cell contact24. For technical reasons the earliest time point that 
could be visualized was the state after 3 minutes. HPF/FS-TEM analyses revealed that the increase of the A5/A3 
ratio temporally correlates with local clustering of VSOP in the glycocalyx of THP-1 cells in early phases, followed 
by the appearance of larger particle clusters in endosomes in later phases of VSOP incubation. As the MPS signal 
changed within seconds after injection of VSOP into cell suspension we suppose that VSOP clusters are formed 
in the glycocalyx immediately after initial contact.
The fast occurrence of VSOP clusters at the membrane and the prompt initiation of endocytosis of the par-
ticles, together with the results of real-time MPS point to a fast diffusion of a part of the VSOP through the 
glycocalyx without steric or electrostatic hindrance. Recent studies showed the size dependence of nanoparticle 
penetration into the glycocalyx and their accumulation there20. Lieleg et al. suggested a window of surface charges 
that enables a charged particle to diffuse within the glycocalyx without electrostatic hindrance30. With a hydro-
dynamic diameter of ~10 nm and a zeta potential of −25 mV31 VSOP are obviously able to diffuse quickly into 
Figure 3. HPF/FS-TEM image showing the glycocalyx of a THP-1 monocyte after incubation with VSOP for 
3 minutes. Black arrows indicate the outer border of the glycocalyx. Scale bar depicts 1 µm.
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the glycocalyx. On the other hand, the clusters that were visible at certain sites of the glycocalyx could indicate 
that at least some of the VSOP interact with or bind to structures of the glycocalyx, such as proteoglycans and 
glycosaminoglycans (GAG). One possible interaction would be a transchelation reaction in which the citrate 
coat of the cationic iron oxide core of the VSOP is replaced by a GAG coat as hypothesized earlier2,18,32. GAG are 
strong chelators due to their high number of sulfation and carboxy groups and such a reaction was recently also 
proposed for citrate-coated gold nanoparticles, for which a high affinity to hyaluronic acid has been observed21. 
The glycocalyx of THP-1 cells has not yet been investigated in detail, however previous observations indicate that 
it mainly contains highly-chelating sulfated chondroitin sulfate GAG33.
To the best of our knowledge this study is the first description of a real-time MPS approach for live analyses 
of interactions between MNP and cells. The combination of real-time MPS and HPF/FS-TEM provides an ideal 
platform to analyze interactions of different MNP with the glycocalyx of various cell types.
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